EN PL
ORIGINAL PAPER
Prevalence of Yersinia spp., Chlamydia trachomatis, Chlamydophila pneumoniae and Borrelia burgdorferi antibodies in healthy blood donors’ sera
 
More details
Hide details
 
Submission date: 2013-09-03
 
 
Final revision date: 2013-11-29
 
 
Acceptance date: 2013-12-02
 
 
Online publication date: 2013-12-24
 
 
Publication date: 2013-12-20
 
 
Reumatologia 2013;51(6):422-428
 
KEYWORDS
TOPICS
ABSTRACT
Aim of the study: Yersinia spp., Chlamydia trachomatis, Chlamydophila pneumoniae and Borrelia burgdorferi are microorganisms from different taxonomic units. In the literature they are described as responsible for different types of arthritis of suspected bacterial origin, as well as concomitant other complications. The aim of the study was to estimate the prevalence of specific bacterial antibodies in a population of healthy people.
Material and methods: The study included 90 healthy blood donors’ sera. Prevalence of antibacterial antibodies was determined by ELISA (enzyme-linked immunosorbent assay) technique.
Results: Detailed analysis showed that, regardless of the antibody class, the most frequently detected antibacterial antibodies in healthy blood donors’ sera were anti-Chlamydophila pneumoniae (55.6%) and anti-Yersinia spp. (52.2%) antibodies. It may indicate a previous infection of this etiology. Much less often anti-Borrelia burgdorferi (12.2%) and anti-Chlamydia trachomatis antibodies (6.6%) were detected. The analysis of the correlation between prevalence of antibodies and donors’ gender and their age did not show specific differences. We observed a high percentage of the co-occurrence of antibodies for 2-4 tested microorganisms in donors’ sera (42.2%). What is more, there was a predominance of sera with antibodies concomitant to anti-Yersinia spp. + anti-Chlamydophila pneumoniae (27.8%). It may indicate cross reactivity or frequent contact with the microorganism and/or previous infection.
Conclusions: The obtained results may significantly reduce the diagnostic value of these serological tests in undifferentiated arthritis. The results clearly show that the serological diagnosis results of arthritis of suspected bacterial origin has to be always done in close correlation with carefully conducted medical history and the clinical picture.
 
REFERENCES (21)
1.
Carter JD, Hudson AP. Reactive arthritis: clinical aspects and medical management. Rheum Dis Clin North Am 2009; 35: 21-44.
 
2.
Carter JD. Bacterial agents in spondyloarthritis: a destiny from diversity? Best Pract Res Clin Rheumatol 2010; 24: 701-714.
 
3.
Hannu T, Puolakkainen M, Leirisalo-Repo M. Chlamydia pneumoniae as a triggering infection in reactive arthritis. Rheumatology 1999; 38: 411-414.
 
4.
Kuipers JG, Zeidler H, Köhler L. How does Chlamydia cause arthritis? Rheum Dis Clin North Am 2003; 29: 613-629.
 
5.
Hannu T, Inman R, Granfors K, Leirisalo-Repo M. Reactive arthritis or postinfections arthritis? Best Pract Res Clin Rheumatol 2006; 20: 419-433.
 
6.
Sieper J, Braun J. Problems and advances in diagnosis of reactive arthritis. J Rheumatol 1999; 26: 1222-1224.
 
7.
Rihl M, Klos A, Köhler L, Kuipers JG. Infection and musculoskeletal conditions: Reactive arthritis. Best Pract Res Clin Rheumatol 2006; 20: 1119-1137.
 
8.
Noworyta J, Brasse-Rumin M, Ząbek J. Ocena wartości serodiagnostyki bakteriologicznej u chorych na niesklasyfikowane zapalenie stawów. Reumatologia 2008; 46: 115-124.
 
9.
Noworyta J, Brasse-Rumin M, Ząbek J. Ocena wartości serodiagnostyki bakteriologicznej u chorych na niesklasyfikowane zapalenie stawów. Część II. Analiza badań surowic na obecność przeciwciał dla Salmonella enteritidis i Salmonella typhimurium; reakcje krzyżowe z Yersinia enterocolitica O3, Chlamydia trachomatis i Borrelia burgdorferi. Reumatologia 2008; 46: 198-209.
 
10.
Noworyta J, Brasse-Rumin M, Ząbek J. Ocena wartości serodiagnostyki bakteriologicznej u chorych na niesklasyfikowane zapalenie stawów. Część III. Metoda immunoenzymatyczna (ELISA) jako test skriningowy w diagnostyce serologicznej zapaleń stawów o podejrzanej etiologii Borrelia burgdorferi; krzyżowa reaktywność przeciwciał dla Borrelia burgdorferi; z Salmonella enteritidis, Salmonella typhimurium, Yersinia enterocolitica O3, Chlamydia trachomatis. Reumatologia 2009; 47: 249-257.
 
11.
Noworyta J, Brasse-Rumin M, Budziszewska M i wsp. Występowanie, swoistość i krzyżowa reaktywność przeciwciał antybakteryjnych (Yersinia spp., Salmonella enteritidis, Chlamydia trachomatis i Borrelia burgdorferi) oraz ich znaczenie w diagnostyce niesklasyfikowanych zapaleń stawów. Reumatologia 2011; 49: 32-39.
 
12.
Rastawicki W. Humoralna odpowiedź na wybrane antygeny pałeczek Yersinia enterocolitica i Yersinia pseudotuberculosis w przebiegu jersiniozy u ludzi. I. Występowanie i poziom przeciwciał dla somatycznych antygenów pałeczek Yersinia oraz wydzielniczych białek Yop wykrytych odczynem ELISA. Med Dosw Mikrobiol 2006; 58: 303-319.
 
13.
Stojek NM. Seroepidemiologic study on the occurrence of antibodies against Yersinia enterocolitica and Yersinia pseudotuberculosis in urban and rural population of the Lublin region (eastern Poland). Ann Agric Environ Med 1999; 6: 57-61.
 
14.
Mikrogen molekular-biologische Entwicklungs-GmbH: Enzyme immunoassay with recombinant antigens for the detection of IgG, IgA or IgM antibodies against Yersinia enterocolitica and Yersinia pseudotuberculosis in human serum or plasma. Information for use. München 1998.
 
15.
Chmielewski T, Tylewska-Wierzbanowska S. Występowanie przeciwciał swoistych dla Borrelia burgdorferi u ludzi zdrowych na terenie Polski. Przegl Epidemiol 2002; 56: 33-38.
 
16.
Pierer K, Köck T, Freidl W, et al. Prevalence of antibodies to Borrelia burgdorferi flagellin in Styrian blood donors. Zentralbl Bakteriol 1993; 279: 239-243.
 
17.
Weiland T, Kühnl P, Laufs R, Heesemann J. Prevalence of Borrelia burgdorferi antibodies in Hamburg blood donors. Beitr Infusionsther 1992; 30: 92-95.
 
18.
Böhme M, Schembra J, Bocklage H, et al. Infections with Borrelia burgdorferi in Wurzburg blood donors: antibody prevalence, clinical aspects and pathogen detection in antibody positive donors. Beitr Infusionsther 1992; 30: 96-99.
 
19.
Podsiadły E, Kruk M, Przyłuski J, et al. Prevalence of Chlamydia pneumoniae antibodies in patients with coronary heart disease. Przegl Epidemiol 2001; 55: 253-260.
 
20.
Świerkot J, Choroszy-Król I, Marczyńska-Gruszecka K i wsp. Rola badań diagnostycznych w identyfikacji zakażeń Chlamydia trachomatis w reaktywnych zapaleniach stawów. Pol Arch Med Wewn 2003; 110: 711-718.
 
21.
Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microb Rev 1995; 8: 451-461.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top